Class IIOngoing
Inventia Healthcare Limited recalls Chlorthalidone Tablets
Recall date · record updated Sep 23, 2026 · Source: U.S. Food and Drug Administration (openFDA drug enforcement)
Check your product against the names and codes above. The FDA enforcement record lists the recall as voluntary: firm initiated; it does not state a consumer remedy, so follow the firm’s notice or the FDA link.
- Company
- Inventia Healthcare Limited
- Reason
- Failed Dissolution Specifications
- Hazard
- FDA Class II: may cause temporary or medically reversible adverse health consequences (FDA definition).
- Who’s affected
- U.S. Nationwide
- Where
- Nationwide
- Official notice
- www.accessdata.fda.gov/scripts/ires/index.cfm?Event=99806…
Products
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDC: 64980-599-01
Codes/lots: Batch # RISA24002; Exp Date: 04/2027Quantity: 13567 bottlesRecall no. D-0852-2026Class II
Update history
- First listed on OVERLOOKED from the official record.
When the agency expands or changes this recall, we update this page and log the change here.
Proof: raw official record (JSON) · fetched from FDA API
More Medicines & devices recalls
Medicines & devicesClass II
American Health Packaging recalls Metoclopramide Tablets
Presence of Foreign Tablets/Capsules
· FDA · Nationwide
Medicines & devicesClass II
Zydus Pharmaceuticals (USA) Inc recalls Hydrocortisone Sodium Succinate for Injection
Failed Impurities/Degradation Specifications.
· FDA · Nationwide
Medicines & devicesClass II
Teva Pharmaceuticals USA, Inc recalls Metoclopramide Tablets
Presence of Foreign Tablets/Capsules
· FDA · Nationwide